Health
U.S. COVID vaccine hopeful using Gates Foundation cash to prepare for human trial – Devdiscourse
The Swiss company’s gene therapy unit is backing the project with technical assistance and supply. Other COVID-19 vaccines use viral vectors, too, though AstraZeneca…
Scientists who normally focus on fixing defective genes said on Friday that up to $2.1 million from the Bill & Melinda Gates Foundation will help them move their COVID-19 vaccine candidate toward 2021 human trials.
Harvard University scientist Luk Vandenberghe and University of Pennsylvania gene therapy head James Wilson said primate safety and efficacy tests have proven promising for their single-dose candidate, targeted for room-temperature storage. “We believe there is real potential,” Vandenberghe…
-
General23 hours agoOne person trapped after school bus and truck crash in regional Victoria
-
Noosa News23 hours agoPortal shift for applications – Proctor
-
General20 hours agoBig Bell Gold mine fined $945,000 over death of worker Paige Counsell
-
Business19 hours agoWhat to buy now with the ASX at a record high